Osteoporosis, bone & mineral

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study

J Clin Endocrinol MetabPublished Population-based retrospective cohort study

Main finding · Major osteoporotic fracturesResult — go to the resultHazard ratio 0.618 95% CI 0.396–0.963

Authors' conclusion

Bisphosphonate therapy significantly reduces fracture risk in premenopausal women with previous osteoporotic fractures, especially at higher cumulative doses. These findings support considering bisphosphonates as a treatment option in premenopausal women at high risk of fractures.

Study context

Population
Premenopausal women with osteoporotic fractures, National Health Insurance Service-National Sample Cohort, South Korea, 2003–2014matched from 2087
Participants
132 vs 396
Exposure
Bisphosphonate users vs nonusers
  • Bisphosphonate usersn = 132
  • Nonusersn = 396reference
Outcome
Incidence of osteoporotic fractures
Methodological detailspropensity score-matched (age and BMI, 1:3), nationwide
  • Propensity score-matched (age and BMI, 1:3)
  • Nationwide

Main finding

Major osteoporotic fractures

Hazard ratio

0.618

95% CI 0.396–0.963

Bisphosphonate usersvs Nonusers
HR 0.618 (95% CI 0.396–0.963)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Major osteoporotic fractures, ibandronate usersIbandronate usersvs Nonusers0.376 (0.164–0.861)
Nonvertebral fractures, ibandronate usersIbandronate usersvs Nonusers0.214 (0.052–0.877)
Major osteoporotic fractures, bisphosphonate use ≥180 daysBisphosphonate use ≥180 daysvs Nonusers0.528 (0.300–0.929)
Nonvertebral fractures, bisphosphonate use ≥180 daysBisphosphonate use ≥180 daysvs Nonusers0.409 (0.187–0.895)

Original publication

Effectiveness of Bisphosphonates in Young Adults With Fragility Fractures: Representative Population-based Cohort Study. J Clin Endocrinol Metab. Published 6 December 2024. doi:10.1210/clinem/dgae850

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.